Clinical Survey of Decreased Blood Flow Rate in Continuous Renal Replacement Therapy: A Retrospective Observational Study

Table 3

Clinical factors associated with the development of decreased blood flow rate, evaluated by univariate Cox hazard regression analyses.

	Univariate analysis
	HR	95% CI	value
Age	1.01	0.99–1.03	0.48
Male	1.02	0.56–1.89	0.94
Height	1.01	0.99–1.04	0.30
SOFA score	1.03	0.95–1.11	0.52
Sepsis or severe infectious diseases	0.87	0.47–1.58	0.64
Heart failure	0.85	0.46–1.58	0.61
Catheter position (jugular vein)	0.64	0.30–1.36	0.24
CVVHDF	1.04	0.49–2.21	0.92
ACT	1.00	0.99–1.01	0.53
Alb	1.05	0.71–1.57	0.80
Hb	1.07	0.96–1.20	0.21
Nephrologist inserted HD catheter	0.93	0.54–1.62	0.80
Physician (over 10 years of experience) inserted HD catheter	1.24	0.71–2.14	0.44

ACT, activating coagulation time; Alb, albumin; CI, confidence interval; CVVHDF, continuous venovenous hemodiafiltration; Hb, hemoglobin; HD, hemodialysis; HR, hazard ratio; SOFA score, sequential organ failure assessment score.